Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised Parallel Open Label Comparison Between 7 and 14 Day Primaquine Combined With 3-day Dihydroartemisinin-piperaquine or 3-day Chloroquine Regimens for Radical Cure of Plasmodium Vivax

NCT01640574 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT01640574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01640574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised Parallel Open Label Comparison Between 7 and 14 Day Primaquine Combined With 3-day Dihydroartemisinin-piperaquine or 3-day Chloroquine Regimens for Radical Cure of Plasmodium Vivax
Lead sponsor
University of Oxford
Phase
Phase 3
Overall status
Completed
Start date
February 29, 2012
Completion date
December 31, 2015
Enrollment
680 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vivax malaria